The NHSCSP and Cervical Cancer Screening Wales should develop implementation plans for the adoption of LBC as the primary means of collecting and processing samples and consult with their respective national purchasing agencies on the preparation of national procurement strategies for LBC technology. NHS organisations should consult with NHSCSP and Cancer Screening Wales before making investments in LBC.
National and local guidelines, protocols or care pathways relating to the collection and processing of a cervical specimen should be changed to reflect the change in practice following adoption of this guidance.
The NHSCSP and Cervical Screening Wales should include measurement of the correct use of LBC as part of an ongoing quality assurance programme.
Local clinical audits of cervical screening could include measures of the correct use of LBC and inadequate specimens.